Metabolex Garners $8,600,000 New Funding

  • Feed Type
  • Date
    11/6/2009
  • Company Name
    Metabolex
  • Mailing Address
    3876 Bay Center Place Hayward, CA 94545
  • Company Description
    Metabolex, Inc. is a privately held pharmaceutical company dedicated to the discovery and development of drugs to treat diabetes and related metabolic disorders.
  • Website
    http://www.metabolex.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $8,600,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    “These funds will enable us to continue to advance our product portfolio including the development of MBX-2982, a potential new therapy for treating type 2 diabetes.”
  • M&A Terms
  • Venture Investor
    Alta Partners
  • Venture Investor
    Venrock
  • Venture Investor
    Versant Ventures
  • Venture Investor
    Bay City Capital
  • Venture Investor
    VantagePoint Venture Partners
  • Venture Investor
    Novo A/S
  • Venture Investor
    Chart Venture Partners
  • Venture Investor
    Merlin BioMed Group
  • Venture Investor
    Birchmere Ventures

By posting a comment, you agree to our terms and conditions.